 Appoints John Purpura as interim Chief Executive Officer. NEW YORK, May 26, 2020 GLOBE NEWSWIRE -- Delcath Systems, Inc. DCTH, an interventional oncology company focused on liver-directed treatment of rare primary and metastatic cancers, today announced that the Board of Directors appointed John Purpura as interim Chief Executive Officer. 